Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Depression: Overview01:18

Depression: Overview

331
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
331
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Long-term Depression01:03

Long-term Depression

2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

165
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
165
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

208
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
208
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

741
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
741

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion.

Nature. Mental health·2026
Same author

Precise strategies for targeted elimination of senescent cells to combat aging and age-related diseases.

Acta biomaterialia·2026
Same author

Positive and negative affect influence learning during exposure therapy: Secondary analysis from a randomized controlled trial.

Journal of anxiety disorders·2026
Same author

"Doing Our Best:" A Qualitative Study of Researcher Challenges Administering Neuromodulation Across Different Phenotypes.

AJOB neuroscience·2026
Same author

Personalized Network-Guided Neuromodulation Enhances Human Working Memory.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Dual Mechanisms of crRNA 3'-Extension-Mediated Cas12a Attenuation Enable Programmable One-Pot CRISPR Diagnostics.

Analytical chemistry·2026

相关实验视频

Updated: Sep 9, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

174

与抑郁症治疗相关的大脑变化:元分析

Gianna M Perez1, Benjamin M Rosenberg2, Wenyi Xu3

  • 1Center for Brain Imaging and Stimulation, Center for Neuromodulation in Depression and Stress Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

NeuroImage. Clinical
|August 31, 2025
PubMed
概括

有效的抑郁症治疗始终降低了右桃体的活动, 这一发现有助于开发用于跟踪严重抑郁症治疗进展的生物标志物.

关键词:
桃体生物标志物抑郁症抑郁症治疗综合分析功能磁共振成像

更多相关视频

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

791
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K

相关实验视频

Last Updated: Sep 9, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

174
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

791
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K

科学领域:

  • 神经成像
  • 精神病学研究
  • 大脑活动

背景情况:

  • 了解治疗后的大脑变化对于精神病学中神经影像的发展至关重要.
  • 研究主要集中在患者与对照者的差异上,不太重视抑郁症治疗后患者内部的变化.
  • 这项研究综合了各种治疗方法的发现,以确定共同的神经机制.

研究的目的:

  • 对抑郁症治疗研究进行基于坐标的元分析.
  • 在治疗前和治疗后发现大脑常见区域的改变.
  • 探索各种治疗抑郁症的共享治疗机制.

主要方法:

  • 使用激活概率估计 (ALE) 进行元分析.
  • 包括来自18项实验的302名受试者的数据.
  • 综合基于任务的fMRI数据来自涉及药理学,心理治疗,ECT,psilocybin和胺的研究.

主要成果:

  • 确定右桃体是研究中一致变化的区域.
  • 在 [30,2,-22] 报告的右桃体MNI坐标峰值.
  • 发现右桃体活动下降与有效的抑郁症治疗有关.

结论:

  • 通过fMRI测量右桃体对抑郁症治疗反应的重要性.
  • 建议右桃体作为潜在的成像生物标志物来追踪治疗效应.
  • 提供基于神经成像的未来抑郁症生物标志物研究的重点领域.